• Something wrong with this record ?

Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway

S. Grusanovic, P. Danek, M. Kuzmina, MK. Adamcova, M. Burocziova, R. Mikyskova, K. Vanickova, S. Kosanovic, J. Pokorna, M. Reinis, T. Brdicka, M. Alberich-Jorda

. 2023 ; 24 (1) : e54729. [pub] 20221107

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23004638

Chronic inflammation represents a major threat to human health since long-term systemic inflammation is known to affect distinct tissues and organs. Recently, solid evidence demonstrated that chronic inflammation affects hematopoiesis; however, how chronic inflammation affects hematopoietic stem cells (HSCs) on the mechanistic level is poorly understood. Here, we employ a mouse model of chronic multifocal osteomyelitis (CMO) to assess the effects of a spontaneously developed inflammatory condition on HSCs. We demonstrate that hematopoietic and nonhematopoietic compartments in CMO BM contribute to HSC expansion and impair their function. Remarkably, our results suggest that the typical features of murine multifocal osteomyelitis and the HSC phenotype are mechanistically decoupled. We show that the CMO environment imprints a myeloid gene signature and imposes a pro-inflammatory profile on HSCs. We identify IL-6 and the Jak/Stat3 signaling pathway as critical mediators. However, while IL-6 and Stat3 blockage reduce HSC numbers in CMO mice, only inhibition of Stat3 activity significantly rescues their fitness. Our data emphasize the detrimental effects of chronic inflammation on stem cell function, opening new venues for treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004638
003      
CZ-PrNML
005      
20231213144537.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.15252/embr.202254729 $2 doi
035    __
$a (PubMed)36341527
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Grusanovic, Srdjan $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000151349630
245    10
$a Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway / $c S. Grusanovic, P. Danek, M. Kuzmina, MK. Adamcova, M. Burocziova, R. Mikyskova, K. Vanickova, S. Kosanovic, J. Pokorna, M. Reinis, T. Brdicka, M. Alberich-Jorda
520    9_
$a Chronic inflammation represents a major threat to human health since long-term systemic inflammation is known to affect distinct tissues and organs. Recently, solid evidence demonstrated that chronic inflammation affects hematopoiesis; however, how chronic inflammation affects hematopoietic stem cells (HSCs) on the mechanistic level is poorly understood. Here, we employ a mouse model of chronic multifocal osteomyelitis (CMO) to assess the effects of a spontaneously developed inflammatory condition on HSCs. We demonstrate that hematopoietic and nonhematopoietic compartments in CMO BM contribute to HSC expansion and impair their function. Remarkably, our results suggest that the typical features of murine multifocal osteomyelitis and the HSC phenotype are mechanistically decoupled. We show that the CMO environment imprints a myeloid gene signature and imposes a pro-inflammatory profile on HSCs. We identify IL-6 and the Jak/Stat3 signaling pathway as critical mediators. However, while IL-6 and Stat3 blockage reduce HSC numbers in CMO mice, only inhibition of Stat3 activity significantly rescues their fitness. Our data emphasize the detrimental effects of chronic inflammation on stem cell function, opening new venues for treatment.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a interleukin-6 $x genetika $x metabolismus $7 D015850
650    12
$a zánět $x metabolismus $7 D007249
650    _2
$a signální transdukce $7 D015398
650    _2
$a hematopoéza $7 D006410
650    _2
$a hematopoetické kmenové buňky $x metabolismus $7 D006412
650    _2
$a transkripční faktor STAT3 $x genetika $x metabolismus $7 D050796
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Daněk, Petr, $d 1991- $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000265522219 $7 xx0311519
700    1_
$a Kuzmina, Maria $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000153737653
700    1_
$a Adamcova, Miroslava K $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000150258155 $7 xx0205682
700    1_
$a Burocziova, Monika $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000314084797
700    1_
$a Mikyskova, Romana $u Department of Immunological and Tumor models, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000268571155
700    1_
$a Vanickova, Karolina $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000347086772
700    1_
$a Kosanovic, Sladjana $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000239144998
700    1_
$a Pokorna, Jana $u Department of Leukocyte signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Reinis, Milan $u Department of Immunological and Tumor models, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000170832898
700    1_
$a Brdicka, Tomas $u Department of Leukocyte signaling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000215604398 $7 xx0140497
700    1_
$a Alberich-Jorda, Meritxell $u Department of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague, University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/000000028093641X
773    0_
$w MED00006590 $t EMBO reports $x 1469-3178 $g Roč. 24, č. 1 (2023), s. e54729
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36341527 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20231213144533 $b ABA008
999    __
$a ok $b bmc $g 1924995 $s 1190847
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 1 $d e54729 $e 20221107 $i 1469-3178 $m Embo reports $n EMBO Rep $x MED00006590
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Archiving options